FIELD: medicine. SUBSTANCE: described are new cyclopeptides of formula I: cyclo-(Arg-A-Asp-R1-R2) wherein A is Gly, R1 is residue of 2-carboxy-8-amino-4-thiapiperolidin-9-one, O-aminomethyl -O1-carboxybiphenyl, 2-aminomethyl-5- carboxymethylthiophene or residue of 2-(3-amino-1-pyrrolid-2-onyl)-4-methylpentanic acid (S)Gly(ANC-2)-Leu or (R)Gly(ANC-2)-Leu, residues being correspondingly connected through peptide bonds; R2 is not defined, and also physicologically acceptable salts thereof. These compounds act as integrine inhibitors and are useful for prophylaxis and treatment of diseases of blood circulation, bones and antitumor therapy, and also as antiviral active agents. EFFECT: improved properties of the title compounds. 6 cl, 6 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
CYCLIC INHIBITORS OF ADHESION | 1997 |
|
RU2184121C2 |
CYCLOPEPTIDES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, METHOD OF ITS PREPARING | 1996 |
|
RU2157379C2 |
CYCLOPEPTIDES, A METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEIR AND A METHOD OF THEIR PREPARING | 1994 |
|
RU2130030C1 |
BIOTIN DERIVATIVES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITIONS AND METHOD OF THEIR PREPARING | 1996 |
|
RU2171807C2 |
CYCLOPEPTIDES OF SALTS THEREOF, METHOD OF PREPARATION THEREOF, PHARMACEUTICAL COMPOSITIONS, METHOD OF PREPARING THEREOF, AND METHOD OF TREATMENT | 1993 |
|
RU2129563C1 |
COMPOSITIONS, CONTAINING CYCLIC PEPTIDES AND METHODS OF APPLYING THEREOF | 2009 |
|
RU2555357C2 |
CYLLOPEPTIDE DERIVATIVES | 1996 |
|
RU2174520C2 |
CYCLOPEPTIDE DERIVATIVES | 1997 |
|
RU2202557C2 |
METHOD FOR PREPARING CYCLO-(ARG-GLY-ASP-D-PHE-N-MEVAL) | 2000 |
|
RU2243974C2 |
CYCLIC INHIBITORS OF ADHESION | 1993 |
|
RU2116081C1 |
Authors
Dates
2000-06-27—Published
1995-04-27—Filed